ElevateBio, LLC
Insider
First SEC filing: July 29, 2020 · Latest: July 29, 2020
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 28, 2022 | KLRS | A | 3,253,796 | $4.61 | $15,000,000 | 16,674,766 Direct | +24.24% | Acquired | -97.5% (price as of 2026-10-02) |
| Aug. 3, 2020 | KLRS | C | 13,420,970 | · | · | 13,420,970 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 3, 2020 | KLRS | C | 20,000,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 3, 2020 | KLRS | Series A-2 Convertible Preferred Stock | Common Stock | · | · | 20,000,000 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| July 29, 2020 | KLRS | Series A-2 Convertible Preferred Stock | 13,420,970 | Direct |